[go: up one dir, main page]

IL122844A0 - Macrolides their preparation and use - Google Patents

Macrolides their preparation and use

Info

Publication number
IL122844A0
IL122844A0 IL12284496A IL12284496A IL122844A0 IL 122844 A0 IL122844 A0 IL 122844A0 IL 12284496 A IL12284496 A IL 12284496A IL 12284496 A IL12284496 A IL 12284496A IL 122844 A0 IL122844 A0 IL 122844A0
Authority
IL
Israel
Prior art keywords
macrolides
preparation
Prior art date
Application number
IL12284496A
Original Assignee
Movartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9513596.8A external-priority patent/GB9513596D0/en
Priority claimed from GBGB9515495.1A external-priority patent/GB9515495D0/en
Application filed by Movartis Ag filed Critical Movartis Ag
Publication of IL122844A0 publication Critical patent/IL122844A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL12284496A 1995-07-04 1996-07-04 Macrolides their preparation and use IL122844A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9513596.8A GB9513596D0 (en) 1995-07-04 1995-07-04 Organic compounds
GBGB9515495.1A GB9515495D0 (en) 1995-07-28 1995-07-28 Organic compounds
PCT/EP1996/002952 WO1997002285A1 (en) 1995-07-04 1996-07-04 Macrolides

Publications (1)

Publication Number Publication Date
IL122844A0 true IL122844A0 (en) 1998-08-16

Family

ID=26307320

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12284496A IL122844A0 (en) 1995-07-04 1996-07-04 Macrolides their preparation and use

Country Status (17)

Country Link
EP (1) EP0836616A1 (en)
JP (1) JPH11509092A (en)
KR (1) KR19990028724A (en)
CN (1) CN1193979A (en)
AR (1) AR006514A1 (en)
AU (1) AU708004B2 (en)
BR (1) BR9609324A (en)
CA (1) CA2224715A1 (en)
CO (1) CO4750713A1 (en)
CZ (1) CZ424297A3 (en)
HU (1) HUP9802320A3 (en)
IL (1) IL122844A0 (en)
NO (1) NO980016L (en)
PL (1) PL324346A1 (en)
SK (1) SK498A3 (en)
TR (1) TR199800001T1 (en)
WO (1) WO1997002285A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
US7368423B1 (en) * 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2611151A1 (en) 2005-06-17 2006-12-28 Novartis Ag Use of sanglifehrin in hcv
US8067024B2 (en) 2006-02-10 2011-11-29 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
CN101289440B (en) * 2007-06-29 2010-08-25 中国热带农业科学院热带生物技术研究所 A kind of polyene macrocycle compound and its preparation method and application
CN102224242B (en) * 2008-09-24 2014-09-24 中国科学院上海有机化学研究所 Novel gene cluster
EP2533784B1 (en) 2010-02-09 2015-04-22 Neurovive Pharmaceutical AB Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201008123D0 (en) 2010-05-17 2010-06-30 Biotica Tech Ltd Novel compounds
AR084217A1 (en) 2010-12-10 2013-05-02 Gilead Sciences Inc MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
CN103619336B (en) 2010-12-20 2017-10-27 纽洛维弗制药有限公司 Sanglifehrin derivatives and preparation methods thereof
JO3063B1 (en) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab Innovative compound and methods for its production
GB201118334D0 (en) 2011-10-24 2011-12-07 Biotica Tech Ltd Novel dosage form
AR091279A1 (en) 2012-06-08 2015-01-21 Gilead Sciences Inc MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
AU2013270672B2 (en) * 2012-06-08 2017-10-19 Gilead Sciences, Inc. Macrocyclic inhibitors of flaviviridae viruses
PT2859009T (en) 2012-06-08 2018-01-18 Gilead Sciences Inc Macrocyclic inhibitors of flaviviridae viruses
MX2019005349A (en) 2016-11-18 2019-08-05 Neurovive Pharmaceutical Ab Use of sanglifehrin macrocyclic analogues as anticancer compounds.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318144D0 (en) * 1993-09-01 1993-10-20 Sandoz Ltd Organic compounds
WO1995015328A1 (en) * 1993-11-30 1995-06-08 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements

Also Published As

Publication number Publication date
PL324346A1 (en) 1998-05-25
CN1193979A (en) 1998-09-23
HUP9802320A2 (en) 1999-02-01
BR9609324A (en) 1999-05-25
NO980016D0 (en) 1998-01-02
NO980016L (en) 1998-03-02
TR199800001T1 (en) 1998-04-21
AU6519396A (en) 1997-02-05
HUP9802320A3 (en) 1999-03-29
EP0836616A1 (en) 1998-04-22
JPH11509092A (en) 1999-08-17
CO4750713A1 (en) 1999-03-31
KR19990028724A (en) 1999-04-15
CZ424297A3 (en) 1998-04-15
AR006514A1 (en) 1999-09-08
SK498A3 (en) 1998-07-08
WO1997002285A1 (en) 1997-01-23
MX9800217A (en) 1998-07-31
AU708004B2 (en) 1999-07-29
CA2224715A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
GB2298422B (en) Compounds and their use
ZA963937B (en) Polysiloxane-polyol macromers their preparation and their use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL122428A0 (en) Minizymes and minribozymes and uses thereof
IL117859A (en) Isothiazolones and their uses
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
IL122215A0 (en) Dolastatin derivatives their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL122844A0 (en) Macrolides their preparation and use
IL119125A (en) Bioinsecticidal matrix and its preparation
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118295A0 (en) 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation
EP0836617A4 (en) Parevins and tachytegrins
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
GB9518154D0 (en) Oligonucleotides and their use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
IL116658A0 (en) Peptides their preparation and use